U.S. Cancer Biopsy Market Growth Opportunities and Forecast to 2028
U.S. Cancer Biopsy Industry Overview The U.S. cancer biopsy market size is expected to reach USD 15.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.0% from 2021 to 2028. The increasing usage of technologically advanced devices for the early detection of diseases is one of the key factors driving the market. U.S. Cancer Biopsy Market Segmentation Grand View Research has segmented the U.S. cancer biopsy market on the basis of type, application, and site (organ): Based on the Type Insights, the market is segmented into Fine-needle Aspiration, Core Biopsy, Surgical Biopsy, Skin Biopsy /Punch Biopsy and Others. The fine-needle aspiration biopsy (FNA) dominated the market in 2020 with a revenue share of more than 30.0%. This can be attributed to the fact that it is a simple and comparatively noninvasive approach that demands a skilled aspirator, coupled with the use of needles, stains, and syring...